Overwhelming majority passes new EMA powers
The European Parliament has adopted regulation that strengthens the EMA's ability to monitor drug and medical equipment shortages in Europe. New EMA groups will be impartial, they say, effectively shutting the door on representatives from the medical industry at large.
BY PETER THOMSEN eu correspondent for Watch medier, translated by daniel pedersen
STRASBOURG – The European Medicines Agency (EMA) is getting a string of new powers to manage drug and medical equipment shortages in Europe, as the European Commission officially adopts an agreement that strengthens the role of the agency on Wednesday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
EMA gains more power to monitor medicines
For subscribers
.jpg&w=384&q=75)
